Adele Fielding Phones & Addresses
-
Rochester, MN
Publications
Us Patents
Method For Limiting The Growth Of Cancer Cells Using An Attenuated Measles Virus
View pageUS Patent:
7393527, Jul 1, 2008
Filed:
Sep 18, 2006
Appl. No.:
11/532879
Inventors:
Stephen James Russell - Rochester MN, US
Adele Fielding - Rochester MN, US
Kah-Whye Peng - Rochester MN, US
Deanna Grote - Rochester MN, US
Adele Fielding - Rochester MN, US
Kah-Whye Peng - Rochester MN, US
Deanna Grote - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A01N 63/00
C12N 7/00
C12N 7/02
C12N 7/04
C12N 15/00
C12N 7/00
C12N 7/02
C12N 7/04
C12N 15/00
US Classification:
424 936, 424 931, 4352351, 435236, 435239
Abstract:
A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 10pfus to about 10pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
Method For Limiting The Growth Of Cancer Cells Using An Attenuated Measles Virus
View pageUS Patent:
7118740, Oct 10, 2006
Filed:
Sep 22, 2000
Appl. No.:
09/668196
Inventors:
Stephen James Russell - Rochester MN, US
Adele Fielding - Rochester MN, US
Kah-Whye Peng - Rochester MN, US
Deanna Grote - Rochester MN, US
Adele Fielding - Rochester MN, US
Kah-Whye Peng - Rochester MN, US
Deanna Grote - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A01N 93/00
C12N 7/00
C12N 7/02
C12N 7/04
C12N 15/00
C12N 7/00
C12N 7/02
C12N 7/04
C12N 15/00
US Classification:
424 936, 424 931, 4352351, 435236, 435239
Abstract:
A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 10pfus to about 10pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
Wikipedia References
